J&J accepts Carlyle's $4.15B bid for diagnostics unit

|By:, SA News Editor

Johnson & Johnson (JNJ) has accepted Carlyle's (CG) $4.15B binding offer for J&J's Ortho-Clinical Diagnostics (OCD) business.

J&J accepted the proposal, which the private-equity firm made in January, after consultation with the relevant works councils and trade unions.

J&J expects the deal to close toward the middle of the year. (PR)